Environmental Effects on Humalog PK/PD in T1D

Randomised, open-label trial of human insulin in type 1 diabetes mellitus (T1D), sponsored by University of Hull. Primary endpoints: Area under the glucose infusion rate curve from 0 hours until the end of clamp and Time from trial product administration until the blood glucose concentration has decreased at least 0.3 mmol/L (5 mg/dL) from the baseline up to 6 hours. Started Jun 2016; status: completed.